Schleiss MR - Search Results

1

Krause PR, Bialek SR, Boppana SB, Griffiths PD, Laughlin CA, Ljungman P, Mocarski ES, Pass RF, Read JS, Schleiss MR, Plotkin SA. Krause PR, et al. Among authors: schleiss mr. Vaccine. 2013 Dec 17;32(1):4-10. doi: 10.1016/j.vaccine.2013.09.042. Epub 2013 Oct 13. Vaccine. 2013. PMID: 24129123 Free PMC article. Review.

2

Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults.

Bernstein DI, Schleiss MR, Berencsi K, Gonczol E, Dickey M, Khoury P, Cadoz M, Meric C, Zahradnik J, Duliege AM, Plotkin S. Bernstein DI, et al. Among authors: schleiss mr. J Infect Dis. 2002 Mar 1;185(5):686-90. doi: 10.1086/339003. Epub 2002 Feb 6. J Infect Dis. 2002. PMID: 11865427 Clinical Trial.

3

Lack of induction of autoantibody responses following immunization with cytomegalovirus (CMV) glycoprotein B (gB) in healthy CMV-seronegative subjects.

Schleiss MR, Bernstein DI, Passo M, Parker S, Meric C, Verdier F, Newkirk MM. Schleiss MR, et al. Vaccine. 2004 Dec 16;23(5):687-92. doi: 10.1016/j.vaccine.2004.06.038. Vaccine. 2004. PMID: 15542191 Clinical Trial.

4

Antiviral therapy of congenital cytomegalovirus infection.

Schleiss MR. Schleiss MR. Semin Pediatr Infect Dis. 2005 Jan;16(1):50-9. doi: 10.1053/j.spid.2004.09.012. Semin Pediatr Infect Dis. 2005. PMID: 15685150 Review.

5

Progress toward an elusive goal: current status of cytomegalovirus vaccines.

Schleiss MR, Heineman TC. Schleiss MR, et al. Expert Rev Vaccines. 2005 Jun;4(3):381-406. doi: 10.1586/14760584.4.3.381. Expert Rev Vaccines. 2005. PMID: 16026251 Review.

6

Nonprimate models of congenital cytomegalovirus (CMV) infection: gaining insight into pathogenesis and prevention of disease in newborns.

Schleiss MR. Schleiss MR. ILAR J. 2006;47(1):65-72. doi: 10.1093/ilar.47.1.65. ILAR J. 2006. PMID: 16391432 Review.

7

Progress in cytomegalovirus vaccine development.

Schleiss M. Schleiss M. Herpes. 2005 Dec;12(3):66-75. Herpes. 2005. PMID: 16393522 Review.

8

Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine.

Schleiss MR, Stroup G, Pogorzelski K, McGregor A. Schleiss MR, et al. Vaccine. 2006 Sep 11;24(37-39):6175-86. doi: 10.1016/j.vaccine.2006.06.077. Epub 2006 Jul 18. Vaccine. 2006. PMID: 16879902

9

Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection.

Schleiss MR, Lacayo JC, Belkaid Y, McGregor A, Stroup G, Rayner J, Alterson K, Chulay JD, Smith JF. Schleiss MR, et al. J Infect Dis. 2007 Mar 15;195(6):789-98. doi: 10.1086/511982. Epub 2007 Feb 6. J Infect Dis. 2007. PMID: 17299708

10

Prospects for development and potential impact of a vaccine against congenital cytomegalovirus (CMV) infection.

Schleiss MR. Schleiss MR. J Pediatr. 2007 Dec;151(6):564-70. doi: 10.1016/j.jpeds.2007.07.015. J Pediatr. 2007. PMID: 18035130 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

209 results

Search Page